Researchers Use a Novel Approach to Design a COVID-19 Antiviral Drug (IMAGE)
Caption
Neutrons and X-rays provided insights on the binding of the COVID-19 virus SARS-CoV-2 protein with a novel inhibitor, BBH-1, formed by combining atomic features of known hepatitis C and SARS-CoV-1 inhibitors (such as Boceprevir and GC-376, upper left).
Credit
Image courtesy of Oak Ridge National Laboratory
Usage Restrictions
Image courtesy of Oak Ridge National Laboratory
License
Original content